Durham, North Carolina, Oct. 21, 2017 -- Guess & Co. Corporation a luxury, industrial, health care and real estate company based in Durham, North Carolina is pleased to announce its first Annual Meeting of Shareholders. The meeting is being held in Durham, North Carolina on Friday, October 27, 2017. Shareholders of Guess & Co. Corporation will meet for the first time to elect permanent directors for the company, and such other business as may come before the meeting. Following the shareholders' meeting, the elected directors will hold their first Board of Directors meeting to appoint permanent officers of the company. The elected directors will serve until the next annual meeting in 2018. The 2017 Annual Meeting of Shareholders will occur at 12:00 PM EST and conclude no later than 1:00 PM EST. The company is allowing approved guests to attend the meeting. Interested parties wishing to attend as guests should contact the company to request an invitation.
|
|||
About Guess & Co. Corporation
Guess & Co. Corporation is a diversified company with four primary business units which are the luxury group, the industrial group, the health care group and the real estate group. We are based in Durham, North Carolina and conduct business in the United States and abroad. Most of our businesses are built organically, and we pursue acquisitions of existing companies that will create value for our customers, employees and shareholders.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1da56c1c-8c7b-45c5-9187-71befba226fb
Media Relations Guess & Co. Corporation 984-201-6390 [email protected]


Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 



